Apimeds Pharmaceuticals US Inc

NYSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/16/2026

Company Profile

IndustryDrug Manufacturers - Specialty & Generic

SectorHealthcare

ExchangeNYSE

Market Capitalization6.62 mln

Float0.56 mln

Earnings Date11/12/2026

Business Description

Apimeds Pharmaceuticals US Inc. is a United Arab Emirates-based company focused on building and managing bitcoin holdings as a core part of its financial strategy. It operates under the ownership of Inscobee Inc.

Key Fundamentals

EPS-36.03

ROE-71.95

ROIC-22.02

ROA-64.23

Interest Cover-4.47

EBITDA, mln-53.82

EV / EBITDA-0.29

EV / EBIT-0.29

Quote Details

Last 4.04

Change -0.35 (-7.97%)

Open 4.16

Volume 42,623

Turnover 172,197

Average Volume 10,966,405

Financial Ratios

Leverage Ratio1.20

Current Ratio0.51

Price / Book0.07

Debt / Equity0.14

Financial Strength

Piotroski F-Score 2 / 9

Short Ratio0.01

Short % of Float9.87

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	-19.52%	2 / 100
1 Month	142%	100 / 100
2 Months	-45.18%	2 / 100
6 Months	-76.37%	1 / 100
1 Year	-78.74%	2 / 100